现代医院Issue(4):49-51,3.DOI:10.3969/j.issn.1671-332X.2015.04.018
新辅助化疗对三阴性乳腺癌患者 Ki67的影响
THE INFLUENCE OF NEOADJUVANT CHEMOTHERAPY FOR TRIPLE NEGATIVE BREAST CANCER IN PATIENTS WITH KI67 NUCLEAR ANTIGENS
张蓉 1曹茵 1张爱玲 1黄河清 1钟慕仪 1王西跃1
作者信息
摘要
Abstract
Objective To discuss the influence of neoadjuvant chemotherapy for Triple Negative Breast Cancer(TNBC) in patients with Ki67 nuclear antigens.Methods 136 patients with TNBC were selected from June 2012 to March 2014 in our Hospitals, and on the basis, immunohistochemical method was used to detect all patients Ki67 expression in breast cancer tissue .The patients were divided into positive group and negative group before chem -otherapy, and on the basis of Ki67 expression changes after chemotherapy and they were divided into yang to yin (A) group, yin to yang(B) group, Yang invariant(C) group and Yin invariant (D) group.Followed up for 5 years, all patients of chemotherapy efficacy and survival were analysed .Results Before chemotherapy, positive group chemo-therapy curative effect was better than negative group , and the difference was statistically significant (p <0.05); After chemotherapy, in the aspect of effect, A group >C group >D group >Bgroup(p <0.05); After chemotherapy, in the aspect of curative effect, A group >C group >D group >Bgroup(p <0.05).Conclusion Neoadjuvant chemo-therapy can change the patients with TNBC cancer Ki 67 positive expression, and it possible to improve the prognosis of patients survival, which is worth for further clinical research .关键词
新辅助化疗/三阴性乳腺癌/核抗原Ki67Key words
neoadjuvant chemotherapy/Triple Negative Breast Cancer/Ki67 nuclear antigens引用本文复制引用
张蓉,曹茵,张爱玲,黄河清,钟慕仪,王西跃..新辅助化疗对三阴性乳腺癌患者 Ki67的影响[J].现代医院,2015,(4):49-51,3.